If this is true, then one of mankind’s greatest enemies may be on the verge of defeat.
According to The Jerusalem Post, Israeli scientists say they have discovered the cure for cancer and will have it ready within a year’s time.
“We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, from Accelerated Evolution Biotechnologies Ltd.
“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market. Our solution will be both generic and personal.”
The Jerusalem Post noted that while the Israeli company may have a drug that works within a year, it may be a decade before we are actually able to distribute it to the population.
The treatment itself is known as MuTaTo (multi-target toxin) and works like an antibiotic to cancer cells. Most drugs nowadays have a problem keeping up with the cancer cell’s ability to mutate receptors targeted by cancer-killing toxins quickly, making many cancer-killing drugs hit or miss. MuTaTo seeks out multiple receptors simultaneously, making it too difficult for the cancer cell to mutate fast enough:
MuTaTo is using a combination of several cancer-targeting peptides for each cancer cell at the same time, combined with a strong peptide toxin that would kill cancer cells specifically. By using at least three targeting peptides on the same structure with a strong toxin, Morad said, “we made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer.”
“The probability of having multiple mutations that would modify all targeted receptors simultaneously decreases dramatically with the number of targets used,” Morad continued. “Instead of attacking receptors one at a time, we attack receptors three at a time – not even cancer can mutate three receptors at the same time.”
Furthermore, many cancer cells activate detoxification mechanisms when in stress from drugs. The cells pump out the drugs or modify them to be non-functional. But Morad said detoxification takes time. When the toxin is strong, it has a high probability of killing the cancer cell before detoxification occurs, which is what he is banking on.
The Israeli scientists also say that the drug will reduce the amount of sickness one feels during other cancer treatments due to the fact that MuTaTo actually targets cancer cells specifically, unlike others which may end up attacking the wrong target. MuTaTo acts more like a sniper rifle than a shotgun when it comes to its target within your body.
The Jerusalem Post noted that while the drug can be generally administered, it will be most effective as a personalized drug:
The MuTaTo cancer treatment will eventually be personalized. Each patient will provide a piece of his biopsy to the lab, which would then analyze it to know which receptors are overexpressed. The individual would then be administered exactly the molecule cocktail needed to cure his disease. However, unlike in the case of AIDS, where patients must take the cocktail throughout their lives, in the case of MuTaTo, the cells would be killed, and the patient could likely stop treatment after only a few weeks.
Let’s hope this report is true. If it is, then one of the biggest killers of mankind has now been defeated after thousands of years.